Claims for Patent: 10,391,096
✉ Email this page to a colleague
Summary for Patent: 10,391,096
| Title: | Method for treating thrombotic disorders using quercetin-containing compositions |
| Abstract: | A method for treating thrombotic disorders using a composition containing quercetin, together with one or more of vitamin B, vitamin C, and folic acid. Also disclosed is a method of improving the efficacy of a blood thinning medication by co-administering a composition containing quercetin, together with one or more of vitamin B, vitamin C, and folic acid to a subject being treated with a blood thinning medication. |
| Inventor(s): | Lines Thomas Christian |
| Assignee: | Quercegen Pharmaceuticals LLC |
| Application Number: | US13272508 |
| Patent Claims: |
Details for Patent 10,391,096
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Bausch Health Us, Llc | IPRIVASK | desirudin | For Injection | 021271 | April 04, 2003 | ⤷ Get Started Free | 2031-10-13 |
| Eli Lilly And Company | XIGRIS | drotrecogin alfa | Injection | 125029 | November 21, 2001 | ⤷ Get Started Free | 2031-10-13 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
